Drug Type Synthetic peptide |
Synonyms PMS 001, PMS-001, PMS001 |
Target |
Action modulators |
Mechanism AMPA receptor modulators(Glutamate receptor ionotropic AMPA modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dementia | Phase 2 | China | 01 Aug 2025 | |
| Acute Ischemic Stroke | Phase 1 | China | 16 Jan 2025 | |
| Alzheimer Disease | Preclinical | China | 30 Jan 2022 | |
| Depressive Disorder, Major | Preclinical | China | 30 Jan 2022 | |
| Unspecified drug dependence | Preclinical | China | 30 Jan 2022 |






